On April 7, Visante CEO Jim Jorgenson discusses opportunities to improve the quality and cost effectiveness of a comprehensive hemophilia treatment plan. This presentation will be transmitted via a satellite symposium originating at the American Academy of Managed Care Pharmacy (AMCP) annual meeting in San Diego, CA.

Share this on Twitter: